Shalini Sharp to Succeed Peter Thornton as Antigenics' Chief (Herpes)
Shalini Sharp to Succeed Peter Thornton as Antigenics' Chief Genetic Engineering News (press release), NY - Jul 24, 2006 third-generation platinum chemotherapeutic; ATRA-IV, a liposomal retinoic acid; AG-707, a therapeutic vaccine for the treatment of genital herpes; AU-801, a Biogen Idec and Elan Announce Availability of Tysabri (Natalizumab DG News - Jul 24, 2006 Herpes infections were slightly more common in patients treated with Tysabri. adverse events in clinical trials were similarly balanced between treatment groups WTC: Surgeons Describe Face-Saving Transplant MedPage Today, NJ - Jul 27, 2006 did experience two episodes of rejection, which required heavy treatment with immunosuppressants one month after having an infection with human herpes virus 1 Caesalpinia pulcherrima: Amazing mystery Boston Globe, United States - Jul 23, 2006 Diseases caused by adenoviruses, herpes viruses, malaria, tuberculosis, and bacteria have and applied it in their version of clinical trials and treatment. The Quigley Corporation Reports Second Quarter Results - Continues Drug Newswire (press release), CT - 19 hours ago studies have begun on our topical compound for the treatment of Diabetic Systemic Radiation, Rheumatoid Arthritis and Ocular and Genital Herpes," continued Mr Biogen Idec en Elan melden beschikbaarheid TYSABRI voor Netherlands Corporate News (persbericht), Netherlands - Jul 24, 2006 Herpes infections were slightly more common in patients treated with TYSABRI. adverse events in clinical trials were similarly balanced between treatment groups
<< Home